Novartis Sues Bayer Over Hemophilia Drug Patent
Swiss drugmaker Novartis AG has sued Bayer AG and its U.S. subsidiary for infringement over the German company's drug Kogenate, a medicine used to treat hemophilia....To view the full article, register now.
Already a subscriber? Click here to view full article